Articles
Medical
–
Addiction
–
CBD
–
Health
–
Wellness
–
Metals
–
Battery Metals
–
Critical Metals
–
Industrial Metals
–
Precious Metals
–
Energy
–
Nuclear
–
Oil & Gas
–
Environment
–
Climate Change
–
Pollution
–
Markets
–
Bonds
–
Commodities
–
Currency
–
Inflation
–
Interest Rates
–
Technology
–
3D Printing
–
5G
–
Artificial Intelligence (AI)
–
Imaging
–
Politics
–
Education
–
Company Profiles
News
Media
Home
|
Disclaimer
|
Newsletter Subscribe
Entheon Biomedical
Home
Articles
Entheon Biomedical
February 18, 2021
February 18, 2021
Entheon Biomedical: Psychedelic-assisted therapy presents a new pathway to solving Canada’s opioid crisis
2021.02.18 Despite improvements in medical technology and billions of dollars injected into treatment
[…]
January 16, 2021
January 16, 2021
Entheon Biomedical makes investment in psychiatric clinic platform
2021.01.16 Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) has completed its first deal
[…]
December 2, 2020
December 2, 2020
Entheon Biomedical hires Dutch research firm to conduct human clinical trial of psychedelic drug DMT
2020.12.02 Opioids belong to a class of medications used to treat pain. Examples
[…]
November 28, 2020
November 28, 2020
Entheon Biomedical: Opioid addiction – a history
2020.11.28 Opioids belong to a class of medications used to treat pain. Examples
[…]
November 12, 2020
November 12, 2020
Entheon Biomedical (CSE:ENBI): Developing a powerful psychedelic-assisted therapy for the treatment of addiction
2020.11.12 Psychedelic drugs, or sometimes called hallucinogens, are shrouded in a mist of
[…]